SEC Form 4/A · accession 0001209191-18-024466
REATA PHARMACEUTICALS INC · RETA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Jason Douglas Wilson
Officer — Chief Financial Officer
Period of report
Mar 23, 2018
Accepted (ET)
Apr 10, 2018 · 12:08 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001358762
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F1,F2 | $11.62 | Mar 23, 2018 | M | 210 | D | — | Jun 15, 2023 | Class B common stock | 210 | 36,231 | D |
Explanation of responses
- F1The options vest in twenty equal quarterly installments beginning on June 15, 2013, subject to continued service through each vesting date.
- F2The Class B common stock is convertible into Class A common stock on a one-for-one basis at the holder's election at any time.
Remarks
Amended form filed solely to indicate 36,231 option shares in column 9.